Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
SUN PHARMA ADVANCED RESEARCH COMPANY LTD	17/B MAHAL INDUSTRIAL ESTATE OFF MAHAKALI CAVES ROAD ANDHERI (EAST) MUMBAI 400093

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07D:HETEROCYCLIC COMPOUNDS

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Aradhye, Jayraj D	Vadodara, IN	2	1
Berrebi-Bertrand, Isabelle	Pace, FR	15	38
Capet, Marc	Melesse, FR	50	248
Desai, Japan Nitinkumar	Vadodara, IN	3	1
Lecomte, Jeanne-Marie	Paris, FR	65	682
Pal, Ranjan Kumar	Vadodara, IN	8	18
Panchal, Bhavesh M	Nagar, IN	2	1
Pathak, Sandeep Pankajbhai	Vadodara, IN	3	1
Pillai, Muthukumaran Natarajan	Vadodara, IN	2	1
Prajapati, Kaushik Dhanjubhai	Pin, IN	1	0
Rana, Dijixa Chandubhai	Vadodara, IN	1	0
Robert, Philippe	Pace, FR	150	1472
Samanta, Biswajit	Vadodara, IN	9	18
Schwartz, Jean-Charles	Paris, FR	72	728
Thennati, Rajamannar	Vadodara, IN	70	137

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Aug 23, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
February 23, 2016	US,9266867,B2   US9266867B2	GRANTED PATENT AS SECOND PUBLICATION
April 10, 2014	US,20140099316,A1   US20140099316A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9266867

Piperidinyl monocarboxylic acids as S1P1 receptor agonists

---

 

Legal Events